Hirslanden and Swiss Medical Network Reach an agreement about the sale of Klinik Belair

Good news for the employees of Klinik Belair and the people living in the Schaffhausen region: Hirslanden and Swiss Medical Network, the two largest private hospital groups in Switzerland, have come to an agreement about the takeover of Klinik Belair in Schaffhausen. Klinik Belair will thus be integrated into Swiss Medical Network on 1 October 2019.

The takeover will guarantee the sustained development of the hospital with its strong local and regional roots and secure valuable jobs. With its employees and doctors, Klinik Belair will continue operating on a stable basis for the inhabitants of Schaffhausen.

One of the reasons for the sale of the Klinik Belair for Hirslanden was its lack of direct connection to another acute hospital, which can be made possible by Swiss Medical Network in close cooperation with doctors. Hirslanden and Swiss Medical Network are delighted to have been able to find a perfect solution for the continued operation of Klinik Belair in Schaffhausen.

Information for media professionals

A press conference will be held in Klinik Belair, Rietstrasse 30, 8200 Schaffhausen on Wednesday, 4 September 2019 at 10:30. Daniel Liedtke, CEO of the Hirslanden Private Hospital Group and Antoine Hubert, Delegate of the Board of Directors of Swiss Medical Network will provide details about the takeover and will be available for questions and interviews.

Hirslanden Private Hospital Group

As of 31 March 2019, the Hirslanden Private Hospital Group consists of 18 hospitals in 11 cantons, many of which have an integrated outpatient surgery centre and emergency department. The Group also operates 3 outpatient clinics, 2 outpatient surgery units, 17 radiology institutes and 5 radiotherapy institutes. It has 2 303 affiliated doctors and 10 442 permanent employees, 510 of whom are doctors.

Hirslanden is the leading private hospital group and the largest medical network in Switzerland. In the 2018/19 financial year, it generated a turnover of 1 778 million Swiss francs. As of 31 March 2019, the Group had treated over 106 851 inpatients with a total of 479 631 inpatient days. In insurance terms, the patient mix consists of 48.7% with basic, 29.5% with semi-private and 21.8% with private insurance.

Hirslanden Private Hospital Group stands for first-class medical quality, made possible with highly qualified, experienced doctors. In medical terms, Hirslanden stands out in the market as a system provider. Interdisciplinary medical competence centres and specialist institutes enable optimal and individual treatment of cases, whatever their level of medical complexity. The private hospital group was formed in 1990 out of the merger of a number of private hospitals, and became part of the international hospital group Mediclinic International plc in 2007.

About Swiss Medical Group

Swiss Medical Network is one of the two private groups of clinics in Switzerland. It has a state-of-the-art medical infrastructure and offers patients first-class care, both outpatient and inpatient, in all specialties. Nearly 2 000 doctors and 3 000 employees work in the group's 17 clinics and six medical centres in 12 cantons and in the country's three linguistic regions. The institutions have a total of about 1 000 beds and more than 51 000 surgical operations are performed each year.

About Mediclinic International plc

Mediclinic is an international private healthcare services group, established in South Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates.

The Group’s core purpose is to enhance the quality of life.

Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.

Mediclinic comprises 78 hospitals, five sub-acute hospitals, 13 day case clinics and 21 outpatient clinics. Hirslanden operates 18 hospitals, two day case clinics and three outpatient clinics in Switzerland with more than 1 900 inpatient beds; Mediclinic Southern Africa operates 53 hospitals, five sub-acute hospitals and nine day case clinics with more than 8 500 inpatient beds; and Mediclinic Middle East operates seven hospitals, two day case clinics and 18 outpatient clinics with more than 900 inpatient beds in the United Arab Emirates.

The Company’s primary listing is on the London Stock Exchange (“LSE”) in the United Kingdom, with secondary listings on the JSE Ltd in South Africa and the Namibian Stock Exchange in Namibia.

Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group based in the United Kingdom and listed on the LSE.

For further information, please contact:  

Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations 
ir@mediclinic.com
+44 (0)20 3786 8181 

Media Queries 
Hirslanden
Frank Nehlig, Head of Corporate Communications 
medien@hirslanden.ch 
+41 44 388 75 85 

FTI Consulting
Brett Pollard/Debbie Scott – UK 
+44 (0)20 3727 1000
Sherryn Schooling – South Africa  
+27 (0)21 487 9000 

James Arnold

Head of Investor Relations
Mediclinic International plc
6th Floor
65 Gresham Street
London EC2V 7NQ
United Kingdom

Frank Nehlig

Head of Corporate Communications
Corporate Office
Boulevard Lilienthal 2
CH-8152 Glattpark